Lipeng Zhai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lipeng Zhai has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Changchun Wang
Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, and School of Pharmaceutical Sciences, Wuhan University, 185 East Lake Road, Wuhan 430071, P.R. China
1 shared publication - Daofeng Dai
State Key Laboratory of Microbial Metabolism, and School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai 200030, China
1 shared publication - Tingting Huang
Department of Chemistry at the Scripps Research Institute, Jupiter, USA
1 shared publication - Wenqing Chen
Department of Anesthesiology, Zhongnan Hospital of Wuhan University, TaiKang Center for Life and Medical Sciences, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China
1 shared publication - Zixin Deng
Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, and Wuhan University School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China
1 shared publication
Latest Publications
- Open Access
- 7 December 2013
- Published by Springer Nature in Microbial Cell Factories
- Vol. 12 (1) , 121
Genetic dissection of the polyoxin building block-carbamoylpolyoxamic acid biosynthesis revealing the “pathway redundancy” in metabolic networks
Polyoxin, a peptidyl nucleoside antibiotic, consists of three building blocks including a nucleoside skeleton, polyoximic acid (POIA), and carbamoylpolyoxamic acid (CPOAA), however, little is known about the “pathway redundancy” of the metabolic networks directing the CPOAA biosynthesis in the cell factories of the polyoxin producer.
- 7 December 2013
- Published by Springer Nature in Microbial Cell Factories
- Vol. 12 (1) , 121
Open AccessGenetic dissection of the polyoxin building block-carbamoylpolyoxamic acid biosynthesis revealing the “pathway redundancy” in metabolic networks
Polyoxin, a peptidyl nucleoside antibiotic, consists of three building blocks including a nucleoside skeleton, polyoximic acid (POIA), and carbamoylpolyoxamic acid (CPOAA), however, little is known about the “pathway redundancy” of the metabolic networks directing the CPOAA biosynthesis in the cell factories of the polyoxin producer.